Mycosis fungoides and Sezary syndrome: Australian clinical practice statement
- Author(s)
- Bhabha, FK; McCormack, C; Wells, J; Campbell, BA; Newland, K; Lade, S; Buelens, O; Joske, D; Shortt, J; Mapp, S; Radeski, D; Hertzberg, M; Khot, A; van der Weyden, C; Khoo, C; Hawkes, E; Prince, HM;
- Details
- Publication Year 2021-02,Volume 62,Issue #1,Page e8-e18
- Journal Title
- Australasian Journal of Dermatology
- Publication Type
- Review
- Abstract
- Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas with distinct clinical presentations, histopathologic features, treatment approaches and outcomes. The cutaneous T-cell lymphomas, which include mycosis fungoides and Sezary syndrome, account for the majority of the cutaneous lymphomas. This Clinical Practice Statement is reflective of the current clinical practice in Australia. An expanded form of the Clinical Practice Statement (and updates), along with helpful patient resources and access to support groups, can be found at the following (http://www.australasianlymphomaalliance.org.au).
- Keywords
- Biopsy; Hematologic Tests; Humans; Mycosis Fungoides/*diagnosis/mortality/*therapy; Neoplasm Staging; Prognosis; Sezary Syndrome/*diagnosis/mortality/*therapy; Skin/pathology; Skin Neoplasms/*diagnosis/mortality/*therapy; Survival Rate; Sezary syndrome; clinical practices statement; cutaneous T-cell lymphoma; management; mycosis fungoides
- Department(s)
- Surgical Oncology; Radiation Oncology; Pathology; Haematology
- PubMed ID
- 33368169
- Publisher's Version
- https://doi.org/10.1111/ajd.13467
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-06-06 07:51:50
Last Modified: 2025-06-06 07:57:04